Tencent Healthcare (China)
Tencent Healthcare is a healthcare digitalization brand offering cloud-, AI-, and big-data-based solutions across medical insurance, healthcare supervision, hospitals, pharmaceuticals and devices, life sciences, and consumer healthcare.
Last updated November 4, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Tencent Healthcare (Tencent Healthcare (China)) is described in Wikidata as a company in Shenzhen, China. Its official site states it is dedicated to integrating cloud computing, medical big data, and medical AI capabilities from within Tencent and its ecosystem to support the digital upgrading of the healthcare industry. The site organizes its offerings into industry solutions spanning medical insurance, healthcare supervision/disease control, hospitals, pharmaceuticals and devices, life sciences, and consumer healthcare, alongside product lines such as Tencent AIMIS (觅影) medical imaging products and cloud products.
History
Wikidata describes Tencent Healthcare (China) as a company in Shenzhen, China. The official site states that Tencent Healthcare is dedicated to integrating cloud computing, medical big data, and medical AI capabilities from within Tencent and its ecosystem to support the digital upgrading of the healthcare industry. The site presents industry solutions across medical insurance, healthcare supervision/disease control, hospitals, pharmaceuticals and devices, life sciences, and consumer healthcare, and lists product lines including Tencent AIMIS (觅影) AI products and cloud products.
Tencent AIMIS (Tencent Miying) AI products for glaucoma and pneumonia received China NMPA Class III medical device registration certificates, as stated on the official Tencent AIMIS cloud products page.
[4]Tencent Healthcare published its digital capability map for the pharmaceutical industry, covering full value chain technological innovation, as announced on its official website.
[1]
Products and positioning
A healthcare digitalization brand integrating Tencent's cloud computing, medical big data, and medical AI capabilities to support the digital upgrading of the healthcare industry.
Tencent AIMIS AI Products
Relying on Tencent's internal AI computing capabilities and a neuron data model based on computer vision technology, it mines massive multimodal medical imaging raw pixels and effective omics features to learn and simulate radiologists' diagnostic approaches, assisting analysis of multiple diseases.
Tencent AIMIS Cloud Products
Relying on Tencent Cloud's storage and technical capabilities, it is dedicated to cloud storage and management of digital medical imaging data, and carries rich SaaS applications in the cloud to provide diagnosis, consultation, and analysis solutions for medical imaging and medical laboratory customers.
Tencent Healthcare Medical Big Data Algorithm Services
Based on Tencent's leading medical big data and AI technologies, it builds image recognition and text post-structuring capabilities in the medical field, performs deep learning, knowledge mining, and modeling on structured data, and commercializes multiple medical AI application models to enable early disease screening and prediction as well as infectious disease prevention and control decision analysis.
Tencent Medipedia Medical Content API
Working with public tertiary Grade-A renowned doctors, it outputs systematic medical science knowledge through encyclopedia entries, articles, videos, and other rich formats, and supports quick API integration to meet content needs of different health business scenarios.
Tencent Healthcare Omics Platform
Provides life sciences industry users with a one-click cloud overall solution with industry characteristics, featuring elastic cloud computing, task scheduling, and management capabilities to help users conveniently and efficiently use Tencent Cloud resources for omics-related data analysis.
Controversies
2022
Tencent fined RMB 500,000 by SAMR for failing to notify concentration in Sinyi Medical equity acquisition
The State Administration for Market Regulation determined that Tencent Holdings' acquisition of equity in Shanghai Sinyi Medical Technology Co., Ltd. constituted illegal implementation of a concentration without lawful notification (with no effect of eliminating or restricting competition), and fined it RMB 500,000. Progress: administrative penalty. Subjects: Tencent Holdings Limited, Shanghai Sinyi Medical Technology Co., Ltd. Scope: healthcare investment.
Recent events
Qingsong Health Group and Tencent Health deepen ecosystem cooperation[7]
Qingsong Health Group and Tencent Health deepened their industry collaboration during the 2026 Tencent Global Digital Ecosystem Summit, with the cooperation providing ecosystem support for expanding the application scenarios and scale of Qingsong Health Group’s evidence-based medicine AI agent.
Sources8 sources
- 1腾讯健康healthcare.tencent.com
- 2关于我们 - 腾讯健康healthcare.tencent.com
- 3腾讯觅影·AI产品 - 产品服务 - 腾讯健康healthcare.tencent.com
- 4腾讯觅影·云产品 - 产品服务 - 腾讯健康healthcare.tencent.com
- 5Tencent Healthcare (China)wikidata.org
- 6Tencent fined RMB 500,000 by SAMR for failing to notify concentration in Sinyi Medical equity acquisitionfinance.sina.com.cn
- 7轻松健康集团深化与腾讯健康的生态合作nbd.com.cn
- 8轻松健康集团与腾讯健康共建BioMed AI 证元芳拓展产业应用场景tech.china.com
Cite this profile: Cite the canonical profile. /brand-wiki/tencent-healthcare-china · Editorial policy · How profiles are compiled